Dimensional Fund Advisors LP Purchases 614,486 Shares of Colgate-Palmolive Company $CL

Dimensional Fund Advisors LP raised its position in shares of Colgate-Palmolive Company (NYSE:CL) by 14.7% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 4,782,711 shares of the company’s stock after buying an additional 614,486 shares during the quarter. Dimensional Fund Advisors LP owned about 0.59% of Colgate-Palmolive worth $382,348,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. lifted its position in Colgate-Palmolive by 1.2% during the second quarter. Vanguard Group Inc. now owns 82,751,689 shares of the company’s stock valued at $7,522,129,000 after acquiring an additional 993,432 shares during the last quarter. Norges Bank acquired a new position in shares of Colgate-Palmolive during the second quarter worth $960,390,000. Diamond Hill Capital Management Inc. lifted its holdings in shares of Colgate-Palmolive by 46.7% during the 3rd quarter. Diamond Hill Capital Management Inc. now owns 8,077,549 shares of the company’s stock valued at $645,719,000 after purchasing an additional 2,572,796 shares during the last quarter. Invesco Ltd. boosted its position in shares of Colgate-Palmolive by 9.1% in the 2nd quarter. Invesco Ltd. now owns 7,489,050 shares of the company’s stock worth $680,755,000 after purchasing an additional 621,841 shares in the last quarter. Finally, Acadian Asset Management LLC grew its stake in Colgate-Palmolive by 42.9% during the 2nd quarter. Acadian Asset Management LLC now owns 6,124,347 shares of the company’s stock worth $556,663,000 after buying an additional 1,839,853 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on CL shares. Jefferies Financial Group increased their price target on Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a research note on Monday, February 2nd. Royal Bank Of Canada upgraded shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective on the stock in a report on Tuesday, December 9th. Rothschild & Co Redburn set a $93.00 target price on shares of Colgate-Palmolive in a research note on Friday, February 13th. TD Cowen reissued a “buy” rating on shares of Colgate-Palmolive in a research report on Monday, February 2nd. Finally, Morgan Stanley raised their price target on shares of Colgate-Palmolive from $87.00 to $100.00 and gave the stock an “overweight” rating in a report on Monday, February 2nd. Eleven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $94.75.

Colgate-Palmolive Stock Performance

NYSE CL opened at $92.56 on Friday. The firm has a market capitalization of $74.61 billion, a P/E ratio of 35.33, a PEG ratio of 4.30 and a beta of 0.28. The stock has a 50-day simple moving average of $88.70 and a two-hundred day simple moving average of $83.01. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.54 and a current ratio of 0.83. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $100.18.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.91 by $0.04. The firm had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.Colgate-Palmolive’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period last year, the company earned $0.91 earnings per share. On average, equities analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st were issued a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend was Wednesday, January 21st. Colgate-Palmolive’s payout ratio is 79.39%.

Insider Activity

In related news, insider Sally Massey sold 15,851 shares of the stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the sale, the insider directly owned 13,751 shares of the company’s stock, valued at approximately $1,306,757.53. This represents a 53.55% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, COO Panagiotis Tsourapas sold 35,000 shares of the firm’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $94.61, for a total transaction of $3,311,350.00. Following the sale, the chief operating officer owned 10,415 shares in the company, valued at approximately $985,363.15. This represents a 77.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 184,683 shares of company stock valued at $17,486,693. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.